Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bindia Jharap

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Current Treatment Options in Gastroenterology|January 18, 2015
Management of severe ulcerative colitisNeeraj Narula, Bindia Jharap, Jean-Frederic Colombel
Gastroenterology|March 2, 2016
ReplyBindia Jharap, Jean-Frederic Colombel, William J Sandborn
Clinical and Translational Gastroenterology|January 8, 2016
Loss of Response to Anti-TNFs: Definition, Epidemiology, and ManagementGiulia Roda, Bindia Jharap, Narula Neeraj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
ReplyRemi Mahmoud, Edo H J Savelkoul, Bindia Jharap, et al.
Inflammatory Bowel Diseases|September 3, 2015
Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel DiseaseKristen K Lee, Bindia Jharap, Elena A Maser, et al.
Journal of Crohn'S & Colitis|October 30, 2020
Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal: A Markov ModelRemi Mahmoud, Chris van Lieshout, Geert W J Frederix, et al.
Inflammatory Bowel Diseases|March 15, 2008
Low and adequately dosed 6-thioguanine: not so bad after allNanne K H de Boer, Bindia Jharap, Chris Mulder, et al.
European Journal of Clinical Pharmacology|October 7, 2019
Thiopurines with low-dose allopurinol (ThiLDA)-a prospective clinical one-way crossover trialS Faraz Chavoushi, Bindia Jharap, Philip Friedrich, et al.
Digestive Diseases and Sciences|June 20, 2020
Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle ContainerJohannes P D Schultheiss, Sandra Altena, Max R Clevers, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 29, 2007
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBDNanne K H de Boer, Adriaan A van Bodegraven, Bindia Jharap, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Current Treatment Options in Gastroenterology|January 18, 2015
Management of severe ulcerative colitisNeeraj Narula, Bindia Jharap, Jean-Frederic Colombel
Gastroenterology|March 2, 2016
ReplyBindia Jharap, Jean-Frederic Colombel, William J Sandborn
Clinical and Translational Gastroenterology|January 8, 2016
Loss of Response to Anti-TNFs: Definition, Epidemiology, and ManagementGiulia Roda, Bindia Jharap, Narula Neeraj, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 6, 2022
ReplyRemi Mahmoud, Edo H J Savelkoul, Bindia Jharap, et al.
Inflammatory Bowel Diseases|September 3, 2015
Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel DiseaseKristen K Lee, Bindia Jharap, Elena A Maser, et al.
Journal of Crohn'S & Colitis|October 30, 2020
Continuation of Anti-TNF in Patients With Ulcerative Colitis in Remission Is Not Cost-effective Compared With Treatment Withdrawal: A Markov ModelRemi Mahmoud, Chris van Lieshout, Geert W J Frederix, et al.
Inflammatory Bowel Diseases|March 15, 2008
Low and adequately dosed 6-thioguanine: not so bad after allNanne K H de Boer, Bindia Jharap, Chris Mulder, et al.
European Journal of Clinical Pharmacology|October 7, 2019
Thiopurines with low-dose allopurinol (ThiLDA)-a prospective clinical one-way crossover trialS Faraz Chavoushi, Bindia Jharap, Philip Friedrich, et al.
Digestive Diseases and Sciences|June 20, 2020
Adherence to Adalimumab Was Not Improved by a Reminder-Based Intervention with an Electronic Needle ContainerJohannes P D Schultheiss, Sandra Altena, Max R Clevers, et al.
Nature Clinical Practice. Gastroenterology & Hepatology|November 29, 2007
Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBDNanne K H de Boer, Adriaan A van Bodegraven, Bindia Jharap, et al.
Pageof 4